101 related articles for article (PubMed ID: 2901140)
1. [The blood pressure profile, or how to establish the minimal effective dose of an antihypertensive agent].
Abetel G
Rev Med Suisse Romande; 1988 Jun; 108(6):529-33. PubMed ID: 2901140
[No Abstract] [Full Text] [Related]
2. Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension.
Spieker C; Vetter W; Zidek W; Vetter H
Arzneimittelforschung; 1989 Nov; 39(11A):1512-4. PubMed ID: 2576202
[TBL] [Abstract][Full Text] [Related]
3. [Value of a blood pressure profile in evaluating 2 antihypertensive agents].
Abetel G; Mérier G; Karly M; Genoud A; Bousquet JC
Schweiz Med Wochenschr; 1984 Dec; 114(48):1746-9. PubMed ID: 6151741
[TBL] [Abstract][Full Text] [Related]
4. [The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension].
Török E; Jávor T; Szám I; Gábor G
Orv Hetil; 1976 Mar; 117(10):593-8. PubMed ID: 1250586
[No Abstract] [Full Text] [Related]
5. Effect of bopindolol on the circadian blood pressure profile in essential hypertension.
Favre L; Adamec R; Boxho G
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S60-3. PubMed ID: 2439823
[TBL] [Abstract][Full Text] [Related]
6. The effect of LB 46 on the blood pressure in essential hypertension.
Duner H
Indian Heart J; 1972 Jun; 24():Suppl 1:236-7. PubMed ID: 4147279
[No Abstract] [Full Text] [Related]
7. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
Kirch W; von Gizycki C
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
[No Abstract] [Full Text] [Related]
8. [Essential arterial hypertension. Antihypertensive effect of the beta adrenergic blockader pindolol].
Torres Zamora M
Prensa Med Mex; 1977; 42(3-4):127-32. PubMed ID: 917991
[No Abstract] [Full Text] [Related]
9. [Treatment of hypertension with the beta blocker Corindolan. Results of a field study].
Staben P; Müller U
Med Welt; 1983 Aug; 34(33-34):909-13. PubMed ID: 6355743
[No Abstract] [Full Text] [Related]
10. [Single daily dose of pindolol in the treatment of arterial hypertension].
Ciaramelli F
Nouv Presse Med; 1978 Sep; 7(31):2761-4. PubMed ID: 30958
[No Abstract] [Full Text] [Related]
11. [Utilization of pindolol in arterial hypertension. Study during rest and during effort].
Tassy J; Jouve A
Nouv Presse Med; 1978 Sep; 7(31):2783-4. PubMed ID: 30964
[No Abstract] [Full Text] [Related]
12. [Bopindolol in the treatment of mild and moderate arterial hypertension].
Monaci R; Morganti G; Cecchin A; Morandini M
Minerva Cardioangiol; 1988 Oct; 36(10):495-7. PubMed ID: 2906412
[No Abstract] [Full Text] [Related]
13. Chronobiological approach to the treatment of essential hypertension: preliminary data.
Lauro R; Reda G; del Mastro S; Ottolenghi L; Sesti G
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):630-6. PubMed ID: 6500760
[TBL] [Abstract][Full Text] [Related]
14. [Ambulatory treatment of so-called "essential" arterial hypertension with pindolol. Short-term study].
Reffo GC; Pitzorno G; Perin S; Forattini C
Minerva Med; 1980 Jan; 71(1):49-54. PubMed ID: 6101911
[TBL] [Abstract][Full Text] [Related]
15. [Arterial hypertension in Cushing's disease: the 24-hour pressure profile without and during treatment with beta-blockers or cyproheptadine].
Prattichizzo FA
G Ital Cardiol; 1994 May; 24(5):533-8. PubMed ID: 7915698
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
Persson I; Ulrich J
Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
[No Abstract] [Full Text] [Related]
17. Position of beta blockers in antihypertensive therapy.
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S1-87. PubMed ID: 2439810
[No Abstract] [Full Text] [Related]
18. [Pindolol in arterial hypertension. Multicentric study with 15 mg. of Viskene (pindolol) in a single daily dose].
Abetel G; Christeler P; Henry M; Karly M; Knobel P; Magnenat G; Morandi D; de Senarclens B; Terrier P
Rev Med Suisse Romande; 1977 Aug; 97(8):367-72. PubMed ID: 929024
[No Abstract] [Full Text] [Related]
19. [Experience with the use of a beta-blocking agent in the community treatment of arterial hypertension].
Bucci A; Catalucci AM; Giampaoli S
Clin Ter; 1981 Jun; 97(5):521-7. PubMed ID: 6115733
[No Abstract] [Full Text] [Related]
20. [Study of pindolol given once daily in a dose of 15 mg in arterial hypertension].
Barraine R; Bouchez C
Nouv Presse Med; 1978 Sep; 7(31):2765-6. PubMed ID: 30959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
